Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Mini Reviews in Medicinal Chemistry|January 18, 2020
Carbazole Derivatives as Kinase-Targeting Inhibitors for Cancer TreatmentJessica Ceramella, Domenico Iacopetta, Alexia Barbarossa, et al.
Pharmaceuticals (Basel, Switzerland)|September 28, 2021
Sub-Micromolar Inhibition of SARS-CoV-2 3CLpro by Natural CompoundsBruno Rizzuti, Laura Ceballos-Laita, David Ortega-Alarcon, et al.
Antioxidants (Basel, Switzerland)|February 24, 2024
Molecular Docking Studies and In Vitro Activity of Paliurus spina-christi Mill Extracts as Pancreatic Lipase InhibitorsFedora Grande, Mariangela Marrelli, Valentina Amodeo, et al.
Cells|June 19, 2019
The Peptide ERα17p Is a GPER Inverse Agonist that Exerts Antiproliferative Effects in Breast Cancer CellsRosamaria Lappano, Christophe Mallet, Bruno Rizzuti, et al.
Molecules (Basel, Switzerland)|July 2, 2021
Toward Multitasking Pharmacological COX-Targeting Agents: Non-Steroidal Anti-Inflammatory Prodrugs with Antiproliferative EffectsFedora Grande, Francesca Giordano, Maria Antonietta Occhiuzzi, et al.
Biomedicines|April 30, 2021
Rutin Is a Low Micromolar Inhibitor of SARS-CoV-2 Main Protease 3CLpro: Implications for Drug Design of Quercetin AnalogsBruno Rizzuti, Fedora Grande, Filomena Conforti, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 3, 2019
AHR and GPER mediate the stimulatory effects induced by 3-methylcholanthrene in breast cancer cells and cancer-associated fibroblasts (CAFs)Francesca Cirillo, Rosamaria Lappano, Leonardo Bruno, et al.
Future Medicinal Chemistry|January 26, 2016
Identification of novel 2-(1H-indol-1-yl)-benzohydrazides CXCR4 ligands impairing breast cancer growth and motilityFedora Grande, Ines Barone, Francesca Aiello, et al.
Future Medicinal Chemistry|October 28, 2017
New insights for the use of quercetin analogs in cancer treatmentDomenico Iacopetta, Fedora Grande, Anna Caruso, et al.
Pageof 7